Levo-tetrahydropalmatine retards the growth of ectopic endometrial implants and alleviates generalized hyperalgesia in experimentally induced endometriosis in rats

Reproductive Sciences

Volumn 18, Issue 1, 2011, Pages 28-45

  Zhao, Ting ^a   Liu, Xishi ^a   Zhen, Xuechu ^b   Guo, Sun Wei ^a  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Endometriosis; Histone deacetylase inhibitor; Hotplate test; Hyperalgesia; L tetrahydropalmatine; Rat

Indexed keywords

ACID SENSING ION CHANNEL; ACID SENSING ION CHANNEL 3; CALCITONIN GENE RELATED PEPTIDE; HISTONE DEACETYLASE 2; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; PROTEIN C FOS; PROTEIN TYROSINE KINASE A; SYNAPTOTAGMIN I; TETRAHYDROPALMATINE; UNCLASSIFIED DRUG; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DRUG ACTIVITY; DRUG EFFICACY; DRUG MEGADOSE; ENDOMETRIOSIS; FEMALE; HYPERALGESIA; IMMUNOREACTIVITY; IMPLANT; LOW DRUG DOSE; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SPINAL GANGLION; THERMAL STIMULATION; TREATMENT RESPONSE;

ANALGESICS, NON-NARCOTIC; ANIMALS; BERBERINE ALKALOIDS; CALCITONIN GENE-RELATED PEPTIDE; DISEASE MODELS, ANIMAL; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; HISTONE DEACETYLASE 2; HOT TEMPERATURE; HYPERALGESIA; INTESTINE, SMALL; NERVE TISSUE PROTEINS; PAIN MEASUREMENT; PERITONEUM; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, N-METHYL-D-ASPARTATE; SODIUM CHANNELS; TRANSCRIPTION FACTOR RELA; VALPROIC ACID;

EID: 79952493375     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719110381928     Document Type: Article

References (64)

1. Olive DL, Lindheim SR, Pritts EA. New medical treatments for endometriosis. Best Pract Res Clin Obstet Gynaecol. 2004;18(2):319-328. (Pubitemid 38786635)
2. Giudice LC, Kao LC. Endometriosis. Lancet. 2004;364(9447):1789-1799.
3. Wheeler JM, Malinak LR. Recurrent endometriosis: incidence, management, and prognosis. Am J Obstet Gynecol. 1983;146(3):247-253. (Pubitemid 13100229)
4. Waller KG, Shaw RW. Gonadotropin-releasing hormone analogues for the treatment of endometriosis: long-term follow-up. Fertil Steril. 1993;59(3):511-515. (Pubitemid 23086304)
5. Kiilholma P, Tuimala R, Kivinen S, Korhonen M, Hagman E. Comparison of the gonadotropin-releasing hormone agonist goserelin acetate alone versus goserelin combined with estrogen-progestogen add-back therapy in the treatment of endometriosis. Fertil Steril. 1995;64(5):903-908.
6. Lessey BA. Medical management of endometriosis and infertility. Fertil Steril. 2000;73(6):1089-1096. (Pubitemid 30336748)
7. Bulun SE, Lin Z, Imir G, et al. Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment. Pharmacol Rev. 2005;57(3):359-383. (Pubitemid 41196955)
8. Nothnick WB, D'Hooghe TM. Medical management of endometriosis: novel targets and approaches towards the development of future treatment regimes. Gynecol Obstet Invest. 2003;55(4):189-198. (Pubitemid 36980730)
9. Guo SW. Epigenetics of endometriosis. Mol Hum Reprod. 2009;15(10):587-607.
10. Lu Y, Nie J, Liu X, Zheng Y, Guo SW. Tricostatin A, a histone deacetylase inhibitor, reduces lesion growth and hyperalgesia in experimentally induced endometriosis in mice. Hum Reprod. 2010;25(4):1014-1025.
11. Berkley KJ, Cason A, Jacobs H, Bradshaw H, Wood E. Vaginal hyperalgesia in a rat model of endometriosis. Neurosci Lett. 2001;306(3):185-188. (Pubitemid 32530830)
12. Latremoliere A, Woolf CJ. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain. 2009;10(9):895-926.
13. Hu JY, Jin GZ. Effect of tetrahydropalmatine analogs on Fos expression induced by formalin-pain. Zhongguo Yao Li Xue Bao. 1999;20(3):193-200.
14. Han YF, Hou LH, Zhou YJ, Wu XK. A survey of TCM treatment for endometriosis. J Tradit Chin Med. 2009;29(1):64-70.
15. Chu H, Jin G, Friedman E, Zhen X. Recent development in studies of tetrahydroprotoberberines: mechanism in antinociception and drug addiction. Cell Mol Neurobiol. 2008;28(4):491-499. (Pubitemid 351637559)
16. Hu JY, Jin GZ. Supraspinal D2 receptor involved in antinociception induced by l-tetrahydropalmatine. Zhongguo Yao Li Xue Bao. 1999;20(8):715-719.
17. Wang GL, Zhu L. Effects of l-tetrahydropalmatine on contraction of isolated rat uterus [Zuo xuan si qing ba ma ting dui da shu li ti zi gong shou suo fan ying de ying xiang in Chinese]. Pharmacol Clin Chinese Materia Medica. 2005;21(2):14-16.
18. Xu JD, Wang W, Yang HX, Li ZQ, Ma LY, Hou XL. Inhibitive effect of tetrahydropalmatine on contractile activity of uterine smoothmuscle strips in virginal rats [YanHuSuo dui wei yun da shu li ti zi gong ping hua ji yun dong de yi zhi zuo yong in Chinese]. J Clin Rehabil Tissue Eng Res. 2007;11(21):4178-4181.
19. Zhao GJ, Ren SL, Wu SG, et al. Effect of L-THP on contraction of blood vessels induced by 5-hydroxytryptamine (in Chinese). Chin J Pharmacol Toxicol. 1988;4:342-348.
20. Xing JF, et al. Effects of dl tetrahydropalmation on rabbit platelet aggregation and experimental cerebral thrombosis in rats (in Chinese). Chin Pharmacol Bull. 1997;13(3):258-10.
21. Gao YJ, Ji RR. c-Fos and pERK, which is a better marker for neuronal activation and central sensitization after noxious stimulation and tissue injury? Open Pain J. 2009;2:11-17.
22. Ikeuchi M, Kolker SJ, Burnes LA, Walder RY, Sluka KA. Role of ASIC3 in the primary and secondary hyperalgesia produced by joint inflammation in mice. Pain. 2008;137(3):662-669.
23. Sevcik MA, Ghilardi JR, Peters CM, et al. Anti-NGF therapy profoundly reduces bone cancer pain and the accompanying increase in markers of peripheral and central sensitization. Pain. 2005;115(1-2):128-141.
24. Heppenstall PA, Lewin GR. Neurotrophins, nociceptors and pain. Curr Opin Anaesthesiol. 2000;13(5):573-576.
25. Binshtok AM, Wang H, Zimmermann K, et al. Nociceptors are interleukin-1beta sensors. J Neurosci. 2008;28(52):14062-14073.
26. Haddad JJ. Onthe enigmaof pain and hyperalgesia: amolecular perspective. Biochem Biophys Res Commun. 2007;353(2):217-224.
27. Osborn L, Kunkel S, Nabel GJ. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc Natl Acad Sci USA. 1989;86(7):2336-2340. (Pubitemid 19102503)
28. Le Bars D, Gozariu M, Cadden SW. Animal models of nociception. Pharmacol Rev. 2001;53(4):597-652. (Pubitemid 33136239)
29. Bannon AW, Malmberg AB. Models of nociception: hot-plate, tail-flick, and formalin tests in rodents. Curr Protoc Neurosci. Chapter 8:Unit 8.9..
30. Chaban VV. Visceral sensory neurons that innervate both uterus and colon express nociceptive TRPv1 and P2X3 receptors in rats. Ethn Dis. 2008;18(2 suppl 2): S2-20-4..
31. Inhaka R, Gentleman RR. R: a language for data analysis and graphics. J Comput Graph Statist. 1996;5:1923-1927.
32. Cui L, Wu T. [L-Tetrahydropalmatine enhances inhibition of cellular proliferation by Vincristine Sulfate in human leukemia cell lines]. Chin Pharmacol Bull. 1995;11(4):348.
33. Lagadec C, Meignan S, Adriaenssens E, et al. TrkA overexpression enhances growth and metastasis of breast cancer cells. Oncogene. 2009;28(18):1960-1970.
34. Kawanami Y, Morimoto Y, Kim H, et al. Calcitonin gene-related peptide stimulates proliferation of alveolar epithelial cells. Respir Res. 2009;10:8.
35. Ribatti D, Nico B, Perra MT, et al. Correlation between NGF/TrkA and microvascular density in human pterygium. Int J Exp Pathol. 2009;90(6):615-620.
36. Okajima K, Harada N. Promotion of insulin-like growth factor-I production by sensory neuron stimulation;molecularmechanism(s) and therapeutic implications. Curr Med Chem. 2008;15(29):3095-3112.
37. Woolf CJ, Thompson SW. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states. Pain. 1991;44(3):293-299.
38. Sun RQ, Lawand NB, Willis WD. The role of calcitonin gene-related peptide (CGRP) in the generation and maintenance of mechanical allodynia and hyperalgesia in rats after intradermal injection of capsaicin. Pain. 2003;104(1-2):201-208. (Pubitemid 36835889)
39. McMahon SB. NGF as a mediator of inflammatory pain. Philos Trans R Soc Lond B Biol Sci. 1996;351(1338):431-440. (Pubitemid 126745351)
40. Basselin M, Chang L, Chen M, Bell JM, Rapoport SI. Chronic administration of valproic acid reduces brain NMDA signaling via arachidonic acid in unanesthetized rats. Neurochem Res. 2008;33(11):2229-2240.
41. Tong C, Ma W, Shin SW, James RL, Eisenach JC. Uterine cervical distension induces cFos expression in deep dorsal horn neurons of the rat spinal cord. Anesthesiology. 2003;99(1):205-211. (Pubitemid 36799052)
42. Stratton P, Sinaii N, Segars J, et al. Return of chronic pelvic pain from endometriosis after raloxifene treatment: a randomized controlled trial. Obstet Gynecol. 2008;111(1):88-96.
43. Ashburner BP, Westerheide SD, Baldwin AS Jr. The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Mol Cell Biol. 2001;21(20):7065-7077. (Pubitemid 32916079)
44. Kaler P, et al. HDAC2 deficiency sensitizes colon cancer cells to TNFalpha-induced apoptosis through inhibition of NF-kappaB activity. Exp Cell Res. 2008;314(7):1507-1518.
45. Ma W, Bisby MA. Increased activation of nuclear factor kappa B in rat lumbar dorsal root ganglion neurons following partial sciatic nerve injuries. Brain Res. 1998;797(2):243-254. (Pubitemid 28332737)
46. Niederberger E, Geisslinger G. The IKK-NF-kappaB pathway: a source for novel molecular drug targets in pain therapy? Faseb J. 2008;22(10):3432-3442.
47. Mattson MP, Camandola S. NF-kappaB in neuronal plasticity and neurodegenerative disorders. J Clin Invest. 2001;107(3):247-254. (Pubitemid 32162153)
48. Chiechio S, Zammataro M, Morales ME, et al. Epigenetic modulation of mGlu2 receptors by histone deacetylase inhibitors in the treatment of inflammatory pain. Mol Pharmacol. 2009;75(5):1014-1020.
49. Hrzenjak A, Moinfar F, Kremser ML, et al. Valproate inhibition of histone deacetylase 2 affects differentiation and decreases proliferation of endometrial stromal sarcoma cells. Mol Cancer Ther. 2006;5(9):2203-2210. (Pubitemid 44530456)
50. Wu Y, Starzinsky-Powitz A, Guo SW. Constitutive and TNFα-stimulated activation of nuclear factor κB (NF-κB) in immortalized endometriotic cells and their suppression by trichostatin A (TSA). Gynecol Obstet Invest. In press.
51. Toth CC, Willis D, Twiss JL, et al. Locally synthesized calcitonin gene-related Peptide has a critical role in peripheral nerve regeneration. J Neuropathol Exp Neurol. 2009;68(3):326-337.
52. Tokushige N, Markham R, Russell P, Fraser IS. High density of small nerve fibres in the functional layer of the endometrium in women with endometriosis. Hum Reprod. 2006;21(3):782-787. (Pubitemid 43372988)
53. Zhang X, Lu B, Huang X, Xu H, Zhou C, Lin J. Endometrial nerve fibers in women with endometriosis, adenomyosis, and uterine fibroids. Fertil Steril. 2009;92(5):1799-1801.
54. Xu JD, Wang W, Yang HX, Li ZQ, Ma LY, Hou XL. Inhibitive effect of tetrahydropalmatine on contractile activity of uterine smooth muscle strips in virginal rats (in Chinese). J Clin Rehabil Tissue Eng Res. 2007;11(21):4178- 4181. (Pubitemid 47054351)
55. Moynihan AT, Hehir MP, Sharkey AM, Robson SC, Europe-Finner GN, Morrison JJ. Histone deacetylase inhibitors and a functional potent inhibitory effect on human uterine contractility. Am J Obstet Gynecol. 2008;199(2):167.e1-167.e7.
56. Novella-Maestre E, Carda C, Noguera I, et al. Dopamine agonist administration causes a reduction in endometrial implants through modulation of angiogenesis in experimentally induced endometriosis. Hum Reprod. 2009;24(5):1025-1035.
57. Novella-Maestre E, et al. Identification and quantification of dopamine receptor 2 in human eutopic and ectopic endometrium: a novel molecular target for endometriosis therapy. Biol Reprod. 2010. [Epub ahead of print].
58. Ren Y. Intramuscular injuction of Rotundine cause serious allergic reactions in 2 cases [Ji Zhu lu tong ding zhi yan zhong guo min fan ying 2 li in Chinese]. Hai nan Medicine. 2001;4:41.
59. Tunnicliff G. Actions of sodium valproate on the central nervous system. J Physiol Pharmacol. 1999;50(3):347-365. (Pubitemid 29473097)
60. Johannessen CU. Mechanisms of action of valproate: a commentatory. Neurochem Int. 2000;37(2-3):103-110. (Pubitemid 30254142)
61. Jentink J, Loane MA, Dolk H, et al. Valproic acid monotherapy in pregnancy and major congenital malformations. N Engl J Med. 2010;362(23):2185- 2193.
62. Liu X, Yuan L, Guo SW. Valproic acid as a therapy for adenomyosis: a comparative case series. Reprod Sci. [Epub ahead of print].
63. Zhang JF, et al. [Determination of Rotundine in human plasma by HPLC and pharmacokinetic studies] in Chinese. J. China Pharmaceutical Univ., 1998. 29(1): p. 67-70.
64. Moyer TP. Therapeutic drug monitoring. In: Burtic AC, Ashwood ER, eds. Tietz Textbook of Clinical Chemistry. Philadelphia: WB Sanders; 1999:873, 876-877.